Format

Send to

Choose Destination
Intensive Care Med. 1996 Apr;22(4):353-5.

The use of inhaled aerosolized prostacyclin (IAP) in the treatment of pulmonary hypertension secondary to pulmonary embolism.

Author information

1
Department of Intensive Care, Sir Charles Gairdner Hospital, Nedlands, Western Australia.

Abstract

OBJECTIVE:

To describe the use of inhaled aerosolized prostacyclin (IAP) in a patient with life-threatening pulmonary hypertension secondary to pulmonary embolism and to discuss the possible use of inhaled prostacyclin in the management of pulmonary embolism.

DESIGN:

Case report.

SETTING:

Intensive care unit of a university teaching hospital.

PATIENTS:

One patient with severe pulmonary hypertension secondary to acute-on-chronic pulmonary embolism.

INTERVENTIONS:

Conventional medical management of massive pulmonary embolism and inhaled aerosolized prostacyclin (IAP).

MEASUREMENTS AND RESULTS:

Description of clinical course, haemodynamic data and gas exchange data.

CONCLUSIONS:

We describe a patient with massive pulmonary embolism for whom the addition of IAP to his therapy appeared to result in a transient improvement in pulmonary haemodynamics and gas exchange.

PMID:
8708174
DOI:
10.1007/bf01700458
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center